Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast: a single-center, phase II study.
about
Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trialWeekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial.
P2860
Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast: a single-center, phase II study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Docetaxel plus epidoxorubicin ...... single-center, phase II study.
@ast
Docetaxel plus epidoxorubicin ...... single-center, phase II study.
@en
type
label
Docetaxel plus epidoxorubicin ...... single-center, phase II study.
@ast
Docetaxel plus epidoxorubicin ...... single-center, phase II study.
@en
prefLabel
Docetaxel plus epidoxorubicin ...... single-center, phase II study.
@ast
Docetaxel plus epidoxorubicin ...... single-center, phase II study.
@en
P2093
P356
P1433
P1476
Docetaxel plus epidoxorubicin ...... single-center, phase II study.
@en
P2093
Andrea de Matteis
Angelo Antonio Mastro
Emanuela Rossi
Ermelinda De Maio
Francesco Nuzzo
Francesco Perrone
Gabriella Landi
Giuseppe D'Aiuto
Vincenzo Labonia
P304
P356
10.1002/CNCR.20335.ABS
P407
P577
2002-02-01T00:00:00Z